PCSK9 and Berardinelli-Seip congenital lipodystrophy: Furthermore, the role for implementation of a protective cardiac treatment (ace-inhibitors, anti-aldosterone drugs, anti-aggregants, PCSK9 inhibitors) should be assessed in adult patients with BSCL.